São Paulo, Brazil, March 26th 2026 – SteinCares, a leading specialty healthcare company in Latin America, today announced Brazil’s Agencia Nacional de Vigilância Sanitária, ANVISA, has approved the registration transfer for Spectrila®, an essential recombinant E. coli asparaginase biologic used in the treatment of Acute Lymphoblastic Leukemia (ALL). SteinCares will now